Drugplain

Provocholine 100 mg/100mg

methacholine chloride · POWDER, FOR SOLUTION · Methapharm Inc.

6 Recalls on Record
Plain English

Provocholine is an inhaled powder medication used to diagnose asthma and airway hyperresponsiveness by measuring how your airways respond to the drug during a breathing test. It is only administered in a medical setting under professional supervision.

Key Facts

Brand Name
Provocholine
Generic Name
methacholine chloride
NDC Code (Product)
64281-100
Manufacturer
Methapharm Inc.
Strength
100 mg/100mg
Dosage Form
POWDER, FOR SOLUTION
Route
RESPIRATORY (INHALATION)
Marketing Status
Application #
NDA019193
Marketing Start
03/27/2013

Recall History

6 Recalls on Record
Class II08/19/2015

Pharmakon Pharmaceuticals

Stability data does not support expiry.

TerminatedVoluntary: Firm initiated
Class II08/19/2015

Pharmakon Pharmaceuticals

Stability data does not support expiry.

TerminatedVoluntary: Firm initiated
Class II04/20/2016

Pharmakon Pharmaceuticals, Inc.

Lack of Assurance of Sterility

TerminatedVoluntary: Firm initiated
Class II08/19/2015

Pharmakon Pharmaceuticals

Stability data does not support expiry.

TerminatedVoluntary: Firm initiated
Class II08/19/2015

Pharmakon Pharmaceuticals

Stability data does not support expiry.

TerminatedVoluntary: Firm initiated
Class II08/19/2015

Pharmakon Pharmaceuticals

Stability data does not support expiry.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

fatigue7 reports
chest discomfort6 reports
dyspnoea6 reports
headache6 reports
dizziness5 reports
drug ineffective5 reports
urticaria5 reports
angioedema4 reports
anxiety4 reports
asthma4 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

1 INDICATIONS AND USAGE Provocholine, used in a methacholine challenge test, is indicated for the diagnosis of bronchial airway hyperreactivity in adults and pediatric patients five years of age and older who do not have clinically apparent asthma. Provocholine, a cholinergic agonist used in a methacholine challenge test, is indicated for the diagnosis of bronchial airway hyperreactivity in adults and pediatric patients five years of age and older who do not have clinically apparent asthma (1)

Dosage & Administration

2 DOSAGE AND ADMINISTRATION The methacholine challenge test should be conducted in a pulmonary function laboratory or clinic, by adequately trained personnel, for safety and accuracy (2.1) Determine baseline FEV1 values to assess whether a patient is able to undergo the methacholine challenge test (2.1) Recommended dosage(s) of Provocholine in the Methacholine Challenge Test is administration of increasing concentrations of Provocholine solution via nebulization (2.2) Administer using either the 5-Breath Dosimeter Dosing Method or the 2-Minute Tidal Breathing Dosing Method with the doubling or quadrupling stepwise protocols (2.4, 2.5) See the Full Prescribing Information for the required reconstitution and dilution procedures prior to use (2.3) See the Full Prescribing Information for the calculation and interpretation of the results (2.6) 2.1 Methacholine Challenge Test Overview Provocholine should be administered in a methacholine challenge test in a pulmonary function laboratory or clinic, by adequately trained personnel, for safety and accuracy, and should be performed only under the responsibility of a healthcare practitioner trained in and thoroughly familiar with all aspects

Contraindications

4 CONTRAINDICATIONS Provocholine is contraindicated in the following: Hypersensitivity to methacholine or other parasympathomimetic agents. Reactions have included rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. Baseline FEV 1 < 60% predicted (adults or pediatric patients) or <1.5 L (adults) Known hypersensitivity to methacholine chloride or other parasympathomimetic agents (4) Baseline FEV 1 <60% predicted (adults or children) or <1.5 L (adults) (4)

Drug Interactions

7 DRUG INTERACTIONS Beta-Adrenergic Blockers The use of beta-adrenergic blockers may impair reversal of Provocholine-caused bronchoconstriction. Beta-Agonists, Anticholinergics, and Theophylline Beta-agonists, anticholinergics, and theophylline inhibit the response of airways to Provocholine; therefore, hold these drugs before Provocholine use for the following duration: • Short-acting β-agonists (e.g., albuterol): 6 hours • Long-acting β-agonists (e.g., salmeterol): 36 hours • Short-acting anti-cholinergics (e.g., ipratropium): 12 hours • Long-acting anti-cholinergics (e.g., tiotropium): ≥168 hours • Oral theophylline: 12-48 hours Oral or Inhaled Corticosteroids, and Inhaled Cromoglycate Regular use of oral or inhaled corticosteroids and inhaled cromoglycate may acutely decrease bronchial responsiveness to Provocholine. However, these drugs may be continued with Provocholine use. Beta-Adrenergic Blockers : May impair reversal of Provocholine-caused bronchoconstriction (7) Beta-Agonists, Anticholinergics, and Theophylline : Inhibit response to Provocholine; therefore, hold these drugs prior to Provocholine use (7) Oral or Inhaled Corticosteroids, and Inhaled Cromyoglycate : May dec

Adverse Reactions

6 ADVERSE REACTIONS The following adverse reactions associated with the use of Provocholine were identified in clinical studies or post marketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Bronchospasm (includes symptoms such as chest tightness, cough or wheezing). Adverse reactions less commonly associated with Provocholine include headache, throat irritation, light-headedness and itching. Adverse reactions associated with Provocholine include headache, throat irritation, light-headedness and itching (6) To report SUSPECTED ADVERSE REACTIONS, contact Methapharm at 1-866-701-4636 or call FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch

Frequently Asked Questions

What is Provocholine used for?

Provocholine is an inhaled powder medication used to diagnose asthma and airway hyperresponsiveness by measuring how your airways respond to the drug during a breathing test. It is only administered in a medical setting under professional supervision.

Is Provocholine a controlled substance?

Provocholine is not classified as a controlled substance by the DEA.

What is the generic name for Provocholine?

The generic name for Provocholine is methacholine chloride. There are 2 other brand versions of methacholine chloride.

What is the NDC code for Provocholine 100 mg/100mg?

The NDC (National Drug Code) for Provocholine 100 mg/100mg is 64281-100, listed by Methapharm Inc..

Product NDC

64281-100

Package NDC

64281-100-06

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)